Filter
567
Filtered Results: 567
Text search:
Medikamente
Featured
Recommendations
75
New Publications
105
Language
Document type
No document type
269
Studies & Reports
91
Guidelines
82
Fact sheets
39
Brochures
36
Resource Platforms
16
Strategic & Response Plan
11
Manuals
8
Training Material
8
Infographics
3
Dashboards/Maps
1
Situation Updates
1
App
1
Online Courses
1
Countries / Regions
Germany
177
Western and Central Europe
29
Global
18
Senegal
14
Indonesia
14
Congo, Democratic Republic of
12
Eastern Europe
12
Benin
11
Burkina Faso
9
Haiti
6
Cameroon
5
Latin America and the Carribbean
5
Africa
4
Togo
3
Mozambique
3
Guinea-Bissau
3
France
3
Mali
3
Angola
3
Switzerland
2
Colombia
2
Ukraine
2
Sierra Leone
2
Malawi
2
Guinea
2
Venezuela
2
West and Central Africa
2
Côte d’Ivoire / Ivory Coast
2
Liberia
2
Ecuador
2
India
2
Rwanda
1
Nigeria
1
Canada
1
Fiji
1
Congo-Brazzaville
1
Niger
1
Burundi
1
Asia
1
Middle East and North Africa
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Luxembourg
1
Belgium
1
East and Southern Africa
1
South Africa
1
Uganda
1
Djibouti
1
Romania
1
Central African Republic
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
116
Clinical Guidelines
27
Public Health
11
Women & Child Health
8
Key Resources
4
Pharmacy & Technologies
4
Capacity Building
1
Toolboxes
Refugee
193
Mental Health
60
TB
51
COVID-19
34
Global Health Education
34
NCDs
24
Malaria
24
Pharmacy
17
NTDs
10
HIV
9
Rapid Response
8
Caregiver
8
Planetary Health
8
Ebola & Marburg
7
Health Financing Toolbox
6
Conflict
5
AMR
3
Zika
2
Specific Hazards
1
Natural Hazards
1
Polio
1
Shown in blue is the estimated annual number of deaths attributed to drug use. Shown in red is theestimated annual number of deaths from drug use disorders. The difference between them is that theyrelate to indirect and direct causes of death, respectively.
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of adverse events (A...
Estimated annual number of deaths from drug use disorders, by type of drug.
Background
The core clinical symptoms of addiction include an enhanced incentive for drug taking (craving), impaired self-control (impulsivity and compulsivity), emotional dysregulation (negative mood) and increased stress reactivity. Symptoms related to impaired self-control involve reduced activi...
Estimated annual number of deaths from drug use disorders per 100,000 people.
Trop. Med. Infect. Dis. 2022, 7, 152. https://doi.org/10.3390/tropicalmed7080152
Infection and Drug Resistance 2020:13 4047–4060
WHO recommends artemisinin-based combination therapies for treating uncomplicated malaria, alongside studies to monitor treatment effectiveness. Given the threat of antimalarial resistance, including partial resistance in several African countries, molecular tools are vital for tracking resistance. ...
Meeting report, Kampala, Uganda,
7–8 November 2023
Launch of the WHO Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010–2019). Key findings
The Severe Malaria Observatory (SMO) is a global knowledge platform designed to enable professionals working on severe malaria, such as researchers, clinicians, public health experts, programme managers, policymakers and technical partners, to access, share and analyse reliable data on malaria compl...
The ACT Consortium was an international research collaboration dedicated to evaluating the effectiveness, safety and implementation of artemisinin-based combination therapies (ACTs) for treating malaria. Operating across multiple countries in Africa and Asia, the consortium conducted over 25 studies...
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex F
The pamphlet "What is Addiction" explains addiction as a chronic, relapsing brain disease characterized by compulsive drug seeking and use, despite harmful consequences. It highlights the dangers of different drug categories, including sedatives, stimulants, and hallucinogens, and their potential he...
The CDC webpage "Types of Insulin" provides an overview of the various insulin types used in diabetes management, categorized by their onset, peak time, and duration of action. It explains terms like onset (how quickly insulin lowers blood sugar), peak time (when insulin is at maximum strength), and...
The IHME webpage discusses alcohol use as a significant global health risk, responsible for over 1.8 million deaths annually. It highlights age-related differences in alcohol's health impacts, with no benefits for individuals aged 15–39 and potential small benefits for those aged 40 and above unde...
The pamphlet "ADHD Medications" provides an overview of medications commonly used to treat ADHD, such as Adderall, Vyvanse, and Ritalin. It explains that these medications do not enhance intelligence and affect individuals differently based on dosage and medical history. Potential dangers of misuse ...
The pamphlet "Marijuana" explains the effects and risks of cannabis use. It describes THC, the psychoactive compound in cannabis, which binds to cannabinoid receptors in the brain, causing effects like relaxation, altered perception, and euphoria. Short-term effects include red eyes, hunger, and anx...
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i...
